Comprehensive Insights into Mechanisms for Ventricular Remodeling in Right Heart Failure

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2025 Jan 1

PMID 39742244

Authors

Dongmei Jiang

Jie Wang

Rui Wang

Yun Wu

Affiliations

Soon will be listed here.

Abstract

Ventricular remodeling in right heart failure is a complex pathological process involving interactions between multiple mechanisms. Overactivation of the neuro-hormonal pathways, activation of the oxidative stress response, expression of cytokines, apoptosis of cardiomyocytes, and alterations of the extracellular matrix (ECM) are among the major mechanisms involved in the development of ventricular remodeling in right heart failure. These mechanisms are involved in ventricular remodeling, such as myocardial hypertrophy and fibrosis, leading to the deterioration of myocardial systolic and diastolic function. A deeper understanding of these mechanisms can help develop more effective therapeutic strategies in patients with right heart failure (RHF) to improve patient survival and quality of life. Despite the importance of ventricular remodeling in RHF, there are a limited number of studies in this field. This article explores in-depth historical and current information about the specific mechanisms in ventricular remodeling in RHF, providing a theoretical rationale for recognizing its importance in health and disease.

References

Shi L, Luo J, Wei X, Xu X, Tu L . The protective role of ginsenoside Rg3 in heart diseases and mental disorders. Front Pharmacol. 2024; 15:1327033. PMC: 10926849. DOI: 10.3389/fphar.2024.1327033. View

Fu M, Luo F, Wang E, Jiang Y, Liu S, Peng J . Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway. Front Pharmacol. 2021; 12:755077. PMC: 8576411. DOI: 10.3389/fphar.2021.755077. View

Li H, Liu Q, Yue Y, Wang S, Huang S, Huang L . Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats. Cardiovasc Diagn Ther. 2022; 12(1):88-102. PMC: 8898686. DOI: 10.21037/cdt-21-360. View

Lv Y, Ma P, Wang J, Xu Q, Fan J, Yan L . Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension. Eur J Pharmacol. 2021; 910:174311. DOI: 10.1016/j.ejphar.2021.174311. View

Ye S, Luo W, Khan Z, Wu G, Xuan L, Shan P . Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3. Circ Res. 2020; 126(8):1007-1023. DOI: 10.1161/CIRCRESAHA.119.315861. View

Yasoda A . Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart. Biology (Basel). 2022; 11(6). PMC: 9219612. DOI: 10.3390/biology11060911. View

Song W, Wang H, Wu Q . Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). Gene. 2015; 569(1):1-6. PMC: 4496260. DOI: 10.1016/j.gene.2015.06.029. View

Feng M, Wang D, Wang X, Yang Y, Zhang S . Bai-Hu-Tang regulates endothelin-1 and its signalling pathway in vascular endothelial cells. J Ethnopharmacol. 2021; 284:114812. DOI: 10.1016/j.jep.2021.114812. View

Nakagawa Y, Nishikimi T, Kuwahara K . Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides. 2018; 111:18-25. DOI: 10.1016/j.peptides.2018.05.012. View

10.

Bavishi C, Bangalore S, Messerli F . Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?. Prog Cardiovasc Dis. 2016; 59(3):253-261. DOI: 10.1016/j.pcad.2016.10.002. View

11.

Kowalczyk A, Kleniewska P, Kolodziejczyk M, Skibska B, Goraca A . The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis. Arch Immunol Ther Exp (Warsz). 2014; 63(1):41-52. PMC: 4289534. DOI: 10.1007/s00005-014-0310-1. View

12.

de Man F, Handoko M, van Ballegoij J, Schalij I, Bogaards S, Postmus P . Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail. 2011; 5(1):97-105. DOI: 10.1161/CIRCHEARTFAILURE.111.964494. View

13.

Barki-Harrington L, Perrino C, Rockman H . Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc Res. 2004; 63(3):391-402. DOI: 10.1016/j.cardiores.2004.03.011. View

14.

Oudit G, Sun H, Kerfant B, A Crackower M, Penninger J, Backx P . The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol. 2004; 37(2):449-71. DOI: 10.1016/j.yjmcc.2004.05.015. View

15.

Miyauchi T, Sakai S . Endothelin and the heart in health and diseases. Peptides. 2018; 111:77-88. DOI: 10.1016/j.peptides.2018.10.002. View

16.

Sun H, Nasi-Er B, Wang X, Zhang L, Lu Y, Zhou X . Tragus Nerve Stimulation Suppresses Post-Infarction Ventricular Arrhythmia by Modulating Autonomic Activity and Heterogeneities of Cardiac Receptor Distribution. Med Sci Monit. 2020; 26:e922277. PMC: 7266086. DOI: 10.12659/MSM.922277. View

17.

de Boer R, Nayor M, deFilippi C, Enserro D, Bhambhani V, Kizer J . Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction. JAMA Cardiol. 2018; 3(3):215-224. PMC: 5862778. DOI: 10.1001/jamacardio.2017.4987. View

18.

Carey R, Siragy H . Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev. 2003; 24(3):261-71. DOI: 10.1210/er.2003-0001. View

19.

Huang J, Zhang W, Zhang C, Wang L . Interleukin-17 aggravates right ventricular remodeling via activating STAT3 under both normoxia and hypoxia. BMC Cardiovasc Disord. 2021; 21(1):249. PMC: 8139008. DOI: 10.1186/s12872-021-02069-4. View

20.

Liu Y, Li Y, Li J, Zuo X, Cao Q, Xie W . Inhibiting miR‑1 attenuates pulmonary arterial hypertension in rats. Mol Med Rep. 2021; 23(4). PMC: 7905329. DOI: 10.3892/mmr.2021.11922. View